What Entourage AI does
Entourage AI analyses blood proteomics against a proprietary reference model of a healthy proteome, built from mass-spectrometry data on thousands of people aged 16 to 85, to estimate biological age and give organ-specific health insights. The company opened preorders for consumers in the UK and US, and offers API integration and testing-cohort access for research institutions, longevity clinics and health systems. Entourage AI is a University of Glasgow spinout founded in 2025 by Professor Patrick T. Gunning, who serves as CEO, and opened a Research and Operations Centre in Glasgow's West of Scotland Science Park. The company describes itself as a 'healthspan data' company rather than a diagnostics-only provider.
Entourage AI is a healthcare tool on Falcoscan. Proteomics platform that scores biological age and organ health. Falcoscan rates Entourage AI with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Entourage AI is founded in 2025, currently at Pre_seed stage. Pricing: Paid.